CBD shows promise in curbing opioid cravings
NCT ID NCT03787628
First seen May 01, 2026 · Last updated May 24, 2026 · Updated 5 times
Summary
This study tested whether cannabidiol (CBD) can help people with opioid use disorder reduce cravings and prevent relapse. 35 adults already taking standard medications (buprenorphine or methadone) were randomly given either CBD or a placebo for 28 days. Researchers measured safety, side effects, and changes in craving levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tarzana Treatment Centers
Tarzana, California, 91356, United States
Conditions
Explore the condition pages connected to this study.